Concentriq® drives the world's pathology
The Concentriq digital pathology platform serves both life sciences and clinical labs at enterprise scale. It helps pathologists and scientists harness the full potential of digital pathology and AI with unparalleled speed, efficiency and impact to enhance patient care and fuel innovation.
Enabling anatomic pathology laboratories to achieve 100% digitization and deliver faster, more precise results.
Driving efficiency and insight across the drug R&D value chain, from discovery to development.
Accelerate tomorrow’s breakthroughs today
Modern pathology software helps solve R&D’s biggest challenges. Improve data integrity and quality, run more studies and experiments faster and uncover new insights.
Run a modern, more productive lab
Accelerate your shift to 100% digital diagnosis to improve diagnostic quality, increase efficiency and position your lab for future growth.
AI-powered pathology for the modern laboratory
Concentriq delivers an open platform to serve as a hub for running a range of AI applications, including Proscia’s, your company’s own algorithms and a broad partner portfolio.
Concentriq® delivers value. Proscia delivers trust.
The 2024 KLAS Emerging Company Spotlight recognizes Concentriq as a digital pathology software that overcomes diagnostic challenges and improves lab efficiency.
Download your complimentary copy to get more details.
Rewiring pathology for precision medicine
Precision therapies are beginning to cure diseases once thought untreatable, but we’re just scratching the surface of what’s possible. The true revolution in precision medicine depends on elevating pathology into a digital and AI-driven discipline — one that unlocks profound opportunities to enhance both drug discovery and patient diagnostics.
Latest News & Events
Webinar:
What’s New, What’s Next at Proscia For Life Sciences
Aired March 20, 2025 | Watch On Demand
Join Proscia for an exclusive webinar on the latest advancements shaping digital pathology’s role in AI-driven drug discovery and development. Explore new enhancements to our Concentriq LS platform, real-world data solutions, and AI capabilities designed to accelerate R&D with speed and precision. Get a first look at upcoming innovations, live demos, and expert insights to help drive breakthroughs faster than ever.
Webinar:
What’s New in Concentriq AP: Intelligent Digital Pathology for Modern Laboratories
Aired April 23, 2025 | Watch On Demand
Concentriq AP is now more intelligent than ever with AI-driven capabilities enhancing precision and efficiency in anatomic pathology workflows. Join our product experts for an exclusive walkthrough of our newest features, like AI-powered auto-alignment, expanded DICOM support, and much more.
Press Release
CB Insights Recognizes Proscia Among Most Promising Digital Health Companies Of 2024 & Top Vendor in Diagnostic Digital Pathology Market Landscapes
Article
The Pathologist: Path Predictions - What’s on the horizon for digital and AI developments in 2025? We ask technology leaders for their forecasts.
Press Release
Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients. Owkin’s MSIntuit® CRC v2 to be integrated into Concentriq® software platform
Proscia Leads The Way Forward in Digital Pathology
Proscia Leads The Way Forward in Digital Pathology
We’re proud to be recognized for these outstanding achievements as we advance our mission to change the way we fight diseases like cancer.
Fast Company Next Big Things Award celebrates our pioneering AI-enabled Concentriq platform.
CB Insights named Proscia to its Digital Health 50 list of the world’s most innovative private healthcare companies and recognized us as the #1 vendor in its diagnostic digital pathology market landscapes.
Inc. Magazine Best in Business 2024 honors our contributions to healthcare innovation.